These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 9818594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
    Kroll S, Char DH, Quivey J, Castro J.
    Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
    [Abstract] [Full Text] [Related]

  • 3. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups.
    Augsburger JJ, Gamel JW, Shields JA.
    Trans Am Ophthalmol Soc; 1989 Nov; 87():348-59; discussion 359-61. PubMed ID: 2562523
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S.
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma.
    Kivelä T, Kujala E.
    JAMA Ophthalmol; 2016 Feb; 134(2):238-9. PubMed ID: 26720623
    [No Abstract] [Full Text] [Related]

  • 11. Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply.
    Lane AM, Kim IK, Gragoudas ES.
    JAMA Ophthalmol; 2016 Feb; 134(2):239-40. PubMed ID: 26720744
    [No Abstract] [Full Text] [Related]

  • 12. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B, Grange JD.
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [Abstract] [Full Text] [Related]

  • 13. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P.
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Presenting Symptoms Are Associated with Uveal Melanoma-Related Death.
    Fili M, Seregard S, Stålhammar G.
    Ophthalmology; 2021 Jul; 128(7):1107-1109. PubMed ID: 33253758
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R, Lumbroso-Le Rouic L, Noel G, Feuvret L, Levy C, Delacroix S, Meyer A, Nauraye C, Mazal A, Mammar H, Garcia P, D'Hermies F, Frau E, Plancher C, Asselain B, Schlienger P, Mazeron JJ, Desjardins L.
    Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):780-7. PubMed ID: 16647221
    [Abstract] [Full Text] [Related]

  • 19. Preenucleation radiotherapy, uveal melanoma, and competing risks.
    Kivelä T, Kujala E.
    Arch Ophthalmol; 2008 Apr 01; 126(4):580-1; author reply 581-2. PubMed ID: 18413540
    [No Abstract] [Full Text] [Related]

  • 20. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
    Kujala E, Kivelä T.
    Ophthalmology; 2005 Jun 01; 112(6):1135-44. PubMed ID: 15885792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.